Pharmaceuticals and Europe 1992: The Dynamics of Industrial Change

J Howells
Additional contact information
J Howells: Centre for Urban and Regional Development Studies, University of Newcastle upon Tyne, Newcastle upon Tyne NE1 7RU, England

Environment and Planning A, 1992, vol. 24, issue 1, 33-48

Abstract: This paper provides an analysis of the implications of 1992 on the European pharmaceutical industry and sets it within the wider restructuring of the industry. The creation of a single European pharmaceutical market will, however, be gradual and will often present conflicting tendencies. The response of the major drug companies to the period of rapid technological change associated with the development of biotechnology is assessed. Their financial power together with their control of key knowledge and information assets, in the form of R&D and sales and marketing networks, has been a central element in their survival and growth. It has been presented that the power of large firms in terms of control and vertical integration has shifted away from production to nonproduction assets.

Date: 1992
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (3)

Downloads: (external link)
https://journals.sagepub.com/doi/10.1068/a240033 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:sae:envira:v:24:y:1992:i:1:p:33-48

DOI: 10.1068/a240033

Access Statistics for this article

More articles in Environment and Planning A
Bibliographic data for series maintained by SAGE Publications ().